PROTAC ERRα Degrader-1 is utilized in targeted protein degradation, specifically for degrading estrogen-related receptor alpha (ERRα). This compound is particularly valuable in research focused on understanding the role of ERRα in various diseases, including cancer. By degrading ERRα, it helps in studying the receptor's function and its impact on cellular processes. This approach is also being explored for potential therapeutic applications, especially in cancers where ERRα is overexpressed or dysregulated. The compound's ability to selectively degrade ERRα makes it a promising tool for developing novel treatments targeting this receptor.